Delivery Order SPE2DB25D3201-SPE2DB26FNNQL
- Not listed
- The Defense Logistics Agency awarded a $1,457.94 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Heparin 25,000 Unit/250-1/2 Normal Saline 250mL on September 4, 2025, with an ultimate completion date of September 5, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,761.14 for Heparin 25,000 Unit/250 mL in D5W solution (250 mL units) on September 4, 2025, with an ultimate completion date of September 5, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award. Performance will occur at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,968.72 to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Heparin 25,000 unit/250 ml in D5W solution (250 ml units). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 12, 2025. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a single transaction under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Heparin 25,000 Unit/250 mL in dextrose 5% water solution with a ceiling value of $1,430.46. The award, issued on August 5, 2025, with an ultimate completion date of August 6, 2025, represents a firm fixed price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Heparin 2,000 Unit/2 mL vials with a ceiling value of $1,979.90. This competitively awarded, non-set-aside contract is structured as a firm fixed price delivery order with an ultimate completion date of September 18, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation, to provide 4,563,790,464 units of Heparin 1,000 unit/500 ml-NS 500 ml for a potential value of $1,071.02. The contract has a period of performance through February 28, 2024. Amerisourcebergen Drug Corp is a prime contractor that holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Heparin Sodium 5,000 Unit/0.5 mL injections with a ceiling value of $4,419.10. This is a firm fixed price delivery order with no set-aside designation, issued under competitive procedures. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of September 5, 2025. This delivery order represents a child...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The contract is for the delivery of 1,000 unit/500 ML-NS 500 ML heparin, a critical medical supply, with a potential value of $2,129.71 and a completion date of February 2, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies in the world. The contract, valued at $1,036.50, is for the delivery of 4,564,414,960 units of 500 unit/5 ml heparin solution. This delivery order is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $4,267.07, is for the delivery of 4562939881 - Heparin Sodium 20,000 Unit/mL vials. The contract is a Firm Fixed Price Delivery Order with a completion date of November 30, 2023. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen...
- SPE2DB25D3201Indefinite Delivery Contract
- SPE2DB25D3201-SPE2DB26FNNQLDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,228.90 to AmerisourceBergen Drug Corp for the supply of Heparin 25,000 Unit/250 ML-D5W in 250 ML quantities. This firm fixed price delivery order, issued on October 24, 2025, with an ultimate completion date of October 27, 2025, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award utilized no set-aside designation, indicating it was competitively awarded through open competition. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. As a critical pharmaceutical distributor supporting federal medical procurement needs, AmerisourceBergen serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this prime contract vehicle, which enables the company to supply an extensive range of medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 10/24/25 |